308 Triptolide, Triptonide and Celastrol Alleviates the Proliferation and IFN-γ-induced Immune Dysfunction of Keratinocytes by Inhibiting Mir-17-92

Y. An,W. Zhang,S. Guo,T. Gao,C. Li

DOI: https://doi.org/10.1016/j.jid.2016.06.328

2016-01-01

Abstract:Psoriasis is an autoimmune skin disease, in which the activation of keratinocytes induced by cytokines plays a crucial role in the pathogenesis. Tripterygium wilfordii Hook. f. is a traditional Chinese medicine that can be used for psoriasis therapy for its immunosuppressive effects. However, whether Tripterygium wilfordii Hook. f. can directly repress the cytokines-induced activation of keratinocytes in psoriasis is not known. In the present study, we initially treated normal human keratinocytes with seven active constituents of Tripterygium wilfordii Hook. f. for 24 hours and then performed CCK-8 assay. It turned out that three compounds, including triptolide, triptonide and celastrol, could successfully inhibit the proliferation of keratinocytes with the effective concentration at 5 nM. Furthermore, the mRNA and protein level of STAT1, an important inflammatory transcriptional factor in psoriasis keratinocytes, as well as the expression of phosphorylated STAT1 could be down-regulated in IFN-γ-stimulated keratinocytes by the three compounds, respectively. Moreover, the level of multiple chemokines, including CXCL1, CXCL9, CXCL10 and CXCL16, were all reduced by the pre-treatment of the three compounds in keratinocytes stimulated by IFN-γ for 24 hours. Finally, triptolide, triptonide and celastrol could inhibit the expression of miR-17-92, a miRNA that had been proved to promote the proliferation of keratinocytes and the production of chemokines by maintaining the activation of STAT1 signaling pathway in our previous research. Taken together, our results suggested that triptolide, triptonide and celastrol could inhibit the proliferation and the cytokines-induced immune dysfunction of keratinocytes possibly through the suppression of miR-17-92. Based on our findings, topical application of triptolide, triptonide and celastrol could inhibit the activation of epidermal keratinocytes in psoriasis and may be applied in the therapy of psoriasis in the future.